Xelafaslatide
Highest phase reached
Phase 2
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Protein
- Drug name
- Xelafaslatide
- his his ile tyr leu gly ala val asn tyr ile tyr nh2
- HIS-HIS-ILE-TYR-LEU-GLY-ALA-VAL-ASN-TYR-ILE-TYR-NH2
- l histidyl l histidyl l isoleucyl l tyrosyl l leucylglycyl l alanyl l valyl l asparaginyl ltyrosyl l isoleucyl l tyrosinamide
- L-Histidyl-L-histidyl-L-isoleucyl-L-tyrosyl-L-leucylglycyl-L-alanyl-L-valyl-L-asparaginyl-Ltyrosyl-L-isoleucyl-L-tyrosinamide
- onl 1204
- Onl-1204
- onl1204
- Onl1204
- ONL1204
- onl1204 c terminal nh2
- ONL1204 C-terminal NH2
- ONL1204 Ophthalmic solution
- ONL1204 Ophthalmic Solution
- ONL1204 Ophthalmic solution (Dose A)
- ONL1204 Ophthalmic solution (Dose B)
- xelafaslatida
- Xelafaslatida
- xelafaslatide
- Xelafaslatide
- xelafaslatide [INN]
- XELAFASLATIDE [USAN]
- xelafaslatide inn
- xelafaslatide usan
- CAS registry numbers
- 2040964-58-5
- ChEMBL ID
- CHEMBL6068318
- PubChem compound IDs
- 122677428
- FDA ingredient codes (UNII)
- XNA75YDV3F
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -tide
- Condition
- Glaucoma, Open-Angle
- Highest recorded phase
- 1
- Condition identifier
- EFO:0004190
- Subject identifier
- D005902
- Condition
- Geographic Atrophy
- Highest recorded phase
- 1
- Condition identifier
- EFO:1001492
- Subject identifier
- D057092
- Condition identifier
- EFO_0004190
- Highest recorded phase
- 1
- Condition identifier
- EFO_1001492
- Highest recorded phase
- 1
- Condition identifier
- EFO_1001492
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005150
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005338
- Highest recorded phase
- 1
- Condition identifier
- MONDO_0005464
- Highest recorded phase
- 2
- NCT04744662
- NCT05160805
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Sequences
- Component
- Sequence
- Type
- Protein
- Sequence
- HHIYLGAVNY
Related records
Trials (50)
- A 3-way Cross-over Study on the Effects of QRL-101 on Transcranial Magnetic Stimulation and Nerve Excitability in Healthy Participants
- A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
- A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
- A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
- A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension
- A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma
- A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
- A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
- A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
- A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
- A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
- A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes
- A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers
- A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
- A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
In development for (1)
- Open-angle glaucoma Phase 1